EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Poly‐ d,l‐ lactic acid‐enhanced atrophic scar treatment via transdermal microjet drug delivery in Asians

Suk Bae Seo, Jovian Wan, Lisa Kwin Wah Chan, Kar Wai Alvin Lee, Soo-Bin Kim, Kyu-Ho Yi

Skin Research and Technology · 2024

DOI: 10.1111/srt.13762 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Skin Research and Technology, 2024. Verfasst von Suk Bae Seo und 5 weiteren Autor:innen. Beteiligte Einrichtung: SeoAhSong Dermatologic Clinic, Seoul, South Korea. Hauptthemen laut MEDLINE: Cicatrix, Polyesters, Patient Satisfaction. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acne vulgaris often results in permanent scars, with atrophic scars being the most common type and posing a significant therapeutic challenge due to their prevalence and impact on patients' quality of life. Various treatment options exist, including the use of poly‐ d,l ‐lactic acid delivered via different methods.

Objective

This study aimed to assess the efficacy and safety of poly‐ d,l ‐lactic acid delivered via laser‐assisted needle‐free microjet injection for treating atrophic scars.

Methods

Five Korean participants with atrophic facial scars were recruited. Poly‐ d,l ‐lactic acid solution was administered via the Mirajet system in five sessions, with clinical assessments conducted at baseline, before each session, and at 12‐week and 22‐week follow‐ups. Outcome measures included the Global Aesthetic Improvement Scale and patient satisfaction scores.

Results

Positive results were observed at the 12‐week and 22‐week follow‐ups, with high patient satisfaction and improvements in atrophic scars and skin texture. Mild discomfort and transient side effects were reported, with no adverse events observed during the follow‐up period.

Conclusion

Poly‐ d,l ‐lactic acid delivered by a laser‐assisted needle‐free microjet injector was judged to be effective for improving atrophic the facial area. Further research, particularly through randomized controlled trials, is needed to validate these findings and assess the longer‐term safety and sustainability of outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CicatrixPolyestersPatient SatisfactionHumansFemaleAdultMaleAsian PeopleDrug Delivery SystemsAdministration, CutaneousTreatment OutcomeAtrophyAcne VulgarisYoung Adult

Stichwörter der Autor:innen

acne scaracne vulgarisl‐lactic acidneedle‐free injectorpoly‐dscar

Substanzen

Polyesterspoly(lactide)

Autor:innen und Institutionen

  • SeoAhSong Dermatologic Clinic, Seoul, South Korea.
  • Asia-Pacific Aesthetic Academy, Hong Kong, Hong Kong.
  • EverKeen Medical Centre, Hong Kong, Hong Kong.
  • Department of Oral Biology, Human Identification Research Institute, Division in Anatomy and Developmental Biology, BK21 FOUR Project, Yonsei University College of Dentistry, Seoul, South Korea.
  • Maylin Clinic (Apgujeong), Seoul, South Korea.

Zitieren

APA

Seo, S. B., Wan, J., Chan, L. K. W., Lee, K. W. A., Kim, S. B., & Yi, K. H. (2024). Poly‐ d,l‐ lactic acid‐enhanced atrophic scar treatment via transdermal microjet drug delivery in Asians. Skin Research and Technology. https://doi.org/10.1111/srt.13762

Vancouver

Seo SB, Wan J, Chan LKW, Lee KWA, Kim SB, Yi KH. Poly‐ d,l‐ lactic acid‐enhanced atrophic scar treatment via transdermal microjet drug delivery in Asians. Skin Research and Technology. 2024. doi:10.1111/srt.13762

BibTeX
@article{Seo2024,
  author = {Seo, Suk Bae and Wan, Jovian and Chan, Lisa Kwin Wah and Lee, Kar Wai Alvin and Kim, Soo-Bin and Yi, Kyu-Ho},
  title = {Poly‐ d,l‐ lactic acid‐enhanced atrophic scar treatment via transdermal microjet drug delivery in Asians},
  journal = {Skin Research and Technology},
  year = {2024},
  doi = {10.1111/srt.13762}
}
Kostenlos starten →